nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—urinary bladder cancer—prostate cancer	0.128	0.363	CtDrD
Cisplatin—bone cancer—prostate cancer	0.123	0.348	CtDrD
Cisplatin—testicular cancer—prostate cancer	0.102	0.288	CtDrD
Cisplatin—MT2A—prostate cancer	0.0875	0.346	CbGaD
Cisplatin—NQO1—prostate cancer	0.0381	0.151	CbGaD
Cisplatin—GSTT1—prostate cancer	0.0356	0.141	CbGaD
Cisplatin—CYP4A11—Estrone—prostate cancer	0.034	0.148	CbGbCtD
Cisplatin—GSTM1—prostate cancer	0.0305	0.121	CbGaD
Cisplatin—GSTP1—prostate cancer	0.0282	0.112	CbGaD
Cisplatin—MPO—prostate cancer	0.0238	0.0941	CbGaD
Cisplatin—GSTT1—Etoposide—prostate cancer	0.0222	0.0963	CbGbCtD
Cisplatin—GSTP1—Etoposide—prostate cancer	0.0139	0.0602	CbGbCtD
Cisplatin—ABCC6—Etoposide—prostate cancer	0.0127	0.0553	CbGbCtD
Cisplatin—ABCC3—Conjugated Estrogens—prostate cancer	0.0107	0.0464	CbGbCtD
Cisplatin—NQO1—Doxorubicin—prostate cancer	0.0104	0.0451	CbGbCtD
Cisplatin—PTGS2—prostate cancer	0.00891	0.0353	CbGaD
Cisplatin—ABCC6—Doxorubicin—prostate cancer	0.00869	0.0377	CbGbCtD
Cisplatin—ABCG2—Cabazitaxel—prostate cancer	0.00686	0.0298	CbGbCtD
Cisplatin—ABCG2—Estrone—prostate cancer	0.00671	0.0291	CbGbCtD
Cisplatin—ABCC2—Ethinyl Estradiol—prostate cancer	0.00661	0.0287	CbGbCtD
Cisplatin—ABCC3—Etoposide—prostate cancer	0.00612	0.0266	CbGbCtD
Cisplatin—XDH—Doxorubicin—prostate cancer	0.00543	0.0236	CbGbCtD
Cisplatin—SLC22A2—Estradiol—prostate cancer	0.00522	0.0227	CbGbCtD
Cisplatin—ABCC2—Conjugated Estrogens—prostate cancer	0.00485	0.0211	CbGbCtD
Cisplatin—CYP2B6—Estrone—prostate cancer	0.00472	0.0205	CbGbCtD
Cisplatin—ABCG2—Conjugated Estrogens—prostate cancer	0.00439	0.0191	CbGbCtD
Cisplatin—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0042	0.0183	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—prostate cancer	0.00418	0.0181	CbGbCtD
Cisplatin—CYP2C9—Nilutamide—prostate cancer	0.00416	0.0181	CbGbCtD
Cisplatin—CYP2C9—Bicalutamide—prostate cancer	0.00416	0.0181	CbGbCtD
Cisplatin—ABCG2—Mitoxantrone—prostate cancer	0.00399	0.0173	CbGbCtD
Cisplatin—ABCG2—Estradiol—prostate cancer	0.00385	0.0167	CbGbCtD
Cisplatin—ABCB1—Estramustine—prostate cancer	0.00375	0.0163	CbGbCtD
Cisplatin—ABCC2—Etoposide—prostate cancer	0.00278	0.0121	CbGbCtD
Cisplatin—PTGS2—Etoposide—prostate cancer	0.00275	0.0119	CbGbCtD
Cisplatin—ABCC2—Docetaxel—prostate cancer	0.00255	0.0111	CbGbCtD
Cisplatin—ABCG2—Etoposide—prostate cancer	0.00252	0.0109	CbGbCtD
Cisplatin—CYP2C9—Estrone—prostate cancer	0.00249	0.0108	CbGbCtD
Cisplatin—ABCB1—Cabazitaxel—prostate cancer	0.00247	0.0107	CbGbCtD
Cisplatin—ABCB1—Estrone—prostate cancer	0.00242	0.0105	CbGbCtD
Cisplatin—ABCG2—Docetaxel—prostate cancer	0.0023	0.00999	CbGbCtD
Cisplatin—ABCB1—Ethinyl Estradiol—prostate cancer	0.00216	0.00936	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—prostate cancer	0.0019	0.00824	CbGbCtD
Cisplatin—CYP2C9—Capecitabine—prostate cancer	0.00189	0.0082	CbGbCtD
Cisplatin—GSTT1—urine—prostate cancer	0.00183	0.0567	CbGeAlD
Cisplatin—ABCG2—Doxorubicin—prostate cancer	0.00172	0.00745	CbGbCtD
Cisplatin—ABCB1—Conjugated Estrogens—prostate cancer	0.00158	0.00687	CbGbCtD
Cisplatin—ABCB1—Mitoxantrone—prostate cancer	0.00144	0.00625	CbGbCtD
Cisplatin—CYP2C9—Estradiol—prostate cancer	0.00143	0.00622	CbGbCtD
Cisplatin—ABCB1—Estradiol—prostate cancer	0.00139	0.00603	CbGbCtD
Cisplatin—GSTM1—urine—prostate cancer	0.00135	0.0418	CbGeAlD
Cisplatin—CYP2B6—Doxorubicin—prostate cancer	0.00121	0.00524	CbGbCtD
Cisplatin—ABCB1—Prednisone—prostate cancer	0.00119	0.00519	CbGbCtD
Cisplatin—ABCB1—Etoposide—prostate cancer	0.000907	0.00394	CbGbCtD
Cisplatin—GSTP1—urine—prostate cancer	0.000846	0.0262	CbGeAlD
Cisplatin—ABCB1—Docetaxel—prostate cancer	0.00083	0.0036	CbGbCtD
Cisplatin—MT1A—prostate gland—prostate cancer	0.000808	0.025	CbGeAlD
Cisplatin—ATP7B—prostate gland—prostate cancer	0.000724	0.0224	CbGeAlD
Cisplatin—ABCC6—Podofilox—Etoposide—prostate cancer	0.000692	1	CbGdCrCtD
Cisplatin—MT2A—prostate gland—prostate cancer	0.000673	0.0208	CbGeAlD
Cisplatin—SLC31A2—prostate gland—prostate cancer	0.000661	0.0204	CbGeAlD
Cisplatin—GSTT1—prostate gland—prostate cancer	0.000659	0.0204	CbGeAlD
Cisplatin—ABCB1—Doxorubicin—prostate cancer	0.000619	0.00269	CbGbCtD
Cisplatin—ATP7A—prostate gland—prostate cancer	0.000583	0.018	CbGeAlD
Cisplatin—SLC31A2—seminal vesicle—prostate cancer	0.000559	0.0173	CbGeAlD
Cisplatin—MT1A—renal system—prostate cancer	0.000551	0.017	CbGeAlD
Cisplatin—SOD1—prostate gland—prostate cancer	0.00051	0.0158	CbGeAlD
Cisplatin—CYP4A11—renal system—prostate cancer	0.000507	0.0157	CbGeAlD
Cisplatin—SLC31A1—prostate gland—prostate cancer	0.000497	0.0154	CbGeAlD
Cisplatin—ATP7A—seminal vesicle—prostate cancer	0.000493	0.0152	CbGeAlD
Cisplatin—XDH—prostate gland—prostate cancer	0.000491	0.0152	CbGeAlD
Cisplatin—GSTM1—prostate gland—prostate cancer	0.000485	0.015	CbGeAlD
Cisplatin—ATP7B—urethra—prostate cancer	0.000485	0.015	CbGeAlD
Cisplatin—MT2A—renal system—prostate cancer	0.000459	0.0142	CbGeAlD
Cisplatin—CYP2C9—urine—prostate cancer	0.000453	0.014	CbGeAlD
Cisplatin—GSTT1—renal system—prostate cancer	0.000449	0.0139	CbGeAlD
Cisplatin—SLC31A2—urethra—prostate cancer	0.000443	0.0137	CbGeAlD
Cisplatin—SOD1—seminal vesicle—prostate cancer	0.000431	0.0133	CbGeAlD
Cisplatin—ATP7A—epithelium—prostate cancer	0.000428	0.0132	CbGeAlD
Cisplatin—SLC31A1—seminal vesicle—prostate cancer	0.00042	0.013	CbGeAlD
Cisplatin—ATP7A—renal system—prostate cancer	0.000397	0.0123	CbGeAlD
Cisplatin—ATP7A—urethra—prostate cancer	0.00039	0.0121	CbGeAlD
Cisplatin—ABCC6—renal system—prostate cancer	0.000364	0.0113	CbGeAlD
Cisplatin—ABCC5—prostate gland—prostate cancer	0.000363	0.0112	CbGeAlD
Cisplatin—MT1A—testis—prostate cancer	0.000356	0.011	CbGeAlD
Cisplatin—SOD1—urethra—prostate cancer	0.000341	0.0106	CbGeAlD
Cisplatin—SLC31A2—bone marrow—prostate cancer	0.000341	0.0105	CbGeAlD
Cisplatin—NQO1—prostate gland—prostate cancer	0.00034	0.0105	CbGeAlD
Cisplatin—SLC31A1—renal system—prostate cancer	0.000339	0.0105	CbGeAlD
Cisplatin—XDH—renal system—prostate cancer	0.000335	0.0103	CbGeAlD
Cisplatin—SLC31A1—urethra—prostate cancer	0.000333	0.0103	CbGeAlD
Cisplatin—GSTM1—renal system—prostate cancer	0.000331	0.0102	CbGeAlD
Cisplatin—ATP7B—testis—prostate cancer	0.000319	0.00986	CbGeAlD
Cisplatin—ABCC3—prostate gland—prostate cancer	0.000305	0.00943	CbGeAlD
Cisplatin—GSTP1—prostate gland—prostate cancer	0.000304	0.00939	CbGeAlD
Cisplatin—ATP7A—bone marrow—prostate cancer	0.0003	0.00928	CbGeAlD
Cisplatin—MT2A—testis—prostate cancer	0.000296	0.00916	CbGeAlD
Cisplatin—SLC31A2—testis—prostate cancer	0.000291	0.009	CbGeAlD
Cisplatin—NQO1—seminal vesicle—prostate cancer	0.000288	0.00889	CbGeAlD
Cisplatin—SOD1—bone marrow—prostate cancer	0.000263	0.00812	CbGeAlD
Cisplatin—SLC22A2—renal system—prostate cancer	0.000262	0.00811	CbGeAlD
Cisplatin—MT1A—lymph node—prostate cancer	0.000258	0.00797	CbGeAlD
Cisplatin—GSTP1—seminal vesicle—prostate cancer	0.000257	0.00794	CbGeAlD
Cisplatin—ATP7A—testis—prostate cancer	0.000257	0.00793	CbGeAlD
Cisplatin—SLC31A1—bone marrow—prostate cancer	0.000256	0.00792	CbGeAlD
Cisplatin—NQO1—epithelium—prostate cancer	0.00025	0.00772	CbGeAlD
Cisplatin—ABCC2—prostate gland—prostate cancer	0.000244	0.00754	CbGeAlD
Cisplatin—NQO1—renal system—prostate cancer	0.000232	0.00716	CbGeAlD
Cisplatin—ATP7B—lymph node—prostate cancer	0.000231	0.00714	CbGeAlD
Cisplatin—MPO—epithelium—prostate cancer	0.00023	0.0071	CbGeAlD
Cisplatin—NQO1—urethra—prostate cancer	0.000228	0.00704	CbGeAlD
Cisplatin—SOD1—testis—prostate cancer	0.000225	0.00694	CbGeAlD
Cisplatin—GSTP1—epithelium—prostate cancer	0.000223	0.0069	CbGeAlD
Cisplatin—SLC31A1—testis—prostate cancer	0.000219	0.00677	CbGeAlD
Cisplatin—GSTM1—testis—prostate cancer	0.000214	0.0066	CbGeAlD
Cisplatin—MPO—renal system—prostate cancer	0.000213	0.00659	CbGeAlD
Cisplatin—SLC31A2—lymph node—prostate cancer	0.000211	0.00653	CbGeAlD
Cisplatin—ABCC3—renal system—prostate cancer	0.000208	0.00643	CbGeAlD
Cisplatin—GSTP1—renal system—prostate cancer	0.000207	0.0064	CbGeAlD
Cisplatin—GSTP1—urethra—prostate cancer	0.000203	0.00629	CbGeAlD
Cisplatin—ABCC5—bone marrow—prostate cancer	0.000187	0.00579	CbGeAlD
Cisplatin—ATP7A—lymph node—prostate cancer	0.000186	0.00575	CbGeAlD
Cisplatin—BCHE—prostate gland—prostate cancer	0.000184	0.00569	CbGeAlD
Cisplatin—ABCG2—prostate gland—prostate cancer	0.000178	0.0055	CbGeAlD
Cisplatin—ABCC2—renal system—prostate cancer	0.000166	0.00514	CbGeAlD
Cisplatin—SOD1—lymph node—prostate cancer	0.000163	0.00503	CbGeAlD
Cisplatin—MPO—bone marrow—prostate cancer	0.000161	0.00498	CbGeAlD
Cisplatin—ABCC5—testis—prostate cancer	0.00016	0.00495	CbGeAlD
Cisplatin—SLC31A1—lymph node—prostate cancer	0.000159	0.00491	CbGeAlD
Cisplatin—GSTP1—bone marrow—prostate cancer	0.000157	0.00484	CbGeAlD
Cisplatin—BCHE—seminal vesicle—prostate cancer	0.000156	0.00481	CbGeAlD
Cisplatin—GSTM1—lymph node—prostate cancer	0.000155	0.00479	CbGeAlD
Cisplatin—ABCG2—seminal vesicle—prostate cancer	0.00015	0.00465	CbGeAlD
Cisplatin—NQO1—testis—prostate cancer	0.00015	0.00463	CbGeAlD
Cisplatin—PTGS2—prostate gland—prostate cancer	0.000142	0.00438	CbGeAlD
Cisplatin—MPO—testis—prostate cancer	0.000138	0.00426	CbGeAlD
Cisplatin—ABCC3—testis—prostate cancer	0.000134	0.00415	CbGeAlD
Cisplatin—GSTP1—testis—prostate cancer	0.000134	0.00414	CbGeAlD
Cisplatin—PTGS2—seminal vesicle—prostate cancer	0.00012	0.00371	CbGeAlD
Cisplatin—ABCG2—urethra—prostate cancer	0.000119	0.00368	CbGeAlD
Cisplatin—ABCC5—lymph node—prostate cancer	0.000116	0.00359	CbGeAlD
Cisplatin—CYP2B6—renal system—prostate cancer	0.000112	0.00346	CbGeAlD
Cisplatin—NQO1—lymph node—prostate cancer	0.000109	0.00336	CbGeAlD
Cisplatin—ABCC2—testis—prostate cancer	0.000107	0.00332	CbGeAlD
Cisplatin—PTGS2—epithelium—prostate cancer	0.000104	0.00322	CbGeAlD
Cisplatin—MPO—lymph node—prostate cancer	9.98e-05	0.00309	CbGeAlD
Cisplatin—ABCC3—lymph node—prostate cancer	9.74e-05	0.00301	CbGeAlD
Cisplatin—GSTP1—lymph node—prostate cancer	9.7e-05	0.003	CbGeAlD
Cisplatin—PTGS2—renal system—prostate cancer	9.66e-05	0.00299	CbGeAlD
Cisplatin—PTGS2—urethra—prostate cancer	9.49e-05	0.00293	CbGeAlD
Cisplatin—BCHE—bone marrow—prostate cancer	9.48e-05	0.00293	CbGeAlD
Cisplatin—ABCG2—bone marrow—prostate cancer	9.16e-05	0.00283	CbGeAlD
Cisplatin—ABCB1—prostate gland—prostate cancer	8.77e-05	0.00271	CbGeAlD
Cisplatin—BCHE—testis—prostate cancer	8.1e-05	0.0025	CbGeAlD
Cisplatin—ABCG2—testis—prostate cancer	7.83e-05	0.00242	CbGeAlD
Cisplatin—ABCC2—lymph node—prostate cancer	7.79e-05	0.00241	CbGeAlD
Cisplatin—ABCB1—seminal vesicle—prostate cancer	7.42e-05	0.00229	CbGeAlD
Cisplatin—PTGS2—bone marrow—prostate cancer	7.3e-05	0.00226	CbGeAlD
Cisplatin—CYP2B6—testis—prostate cancer	7.23e-05	0.00223	CbGeAlD
Cisplatin—ABCB1—epithelium—prostate cancer	6.44e-05	0.00199	CbGeAlD
Cisplatin—ABCB1—renal system—prostate cancer	5.98e-05	0.00185	CbGeAlD
Cisplatin—BCHE—lymph node—prostate cancer	5.87e-05	0.00182	CbGeAlD
Cisplatin—ABCB1—urethra—prostate cancer	5.87e-05	0.00181	CbGeAlD
Cisplatin—ABCG2—lymph node—prostate cancer	5.68e-05	0.00175	CbGeAlD
Cisplatin—PTGS2—lymph node—prostate cancer	4.53e-05	0.0014	CbGeAlD
Cisplatin—ABCB1—bone marrow—prostate cancer	4.52e-05	0.0014	CbGeAlD
Cisplatin—ABCB1—testis—prostate cancer	3.86e-05	0.00119	CbGeAlD
Cisplatin—ABCB1—lymph node—prostate cancer	2.8e-05	0.000865	CbGeAlD
Cisplatin—Anorexia—Etoposide—prostate cancer	2.14e-05	0.000326	CcSEcCtD
Cisplatin—Hypersensitivity—Estradiol—prostate cancer	2.13e-05	0.000325	CcSEcCtD
Cisplatin—Body temperature increased—Mitoxantrone—prostate cancer	2.13e-05	0.000325	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	2.13e-05	0.000325	CcSEcCtD
Cisplatin—Muscle spasms—Capecitabine—prostate cancer	2.13e-05	0.000324	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—prostate cancer	2.12e-05	0.000323	CcSEcCtD
Cisplatin—Eye disorder—Prednisone—prostate cancer	2.12e-05	0.000323	CcSEcCtD
Cisplatin—Anaemia—Docetaxel—prostate cancer	2.11e-05	0.000322	CcSEcCtD
Cisplatin—Flushing—Prednisone—prostate cancer	2.1e-05	0.00032	CcSEcCtD
Cisplatin—Pancytopenia—Epirubicin—prostate cancer	2.1e-05	0.00032	CcSEcCtD
Cisplatin—Hypotension—Etoposide—prostate cancer	2.1e-05	0.00032	CcSEcCtD
Cisplatin—Vision blurred—Capecitabine—prostate cancer	2.09e-05	0.000318	CcSEcCtD
Cisplatin—Asthenia—Estradiol—prostate cancer	2.08e-05	0.000317	CcSEcCtD
Cisplatin—Tremor—Capecitabine—prostate cancer	2.07e-05	0.000316	CcSEcCtD
Cisplatin—Ill-defined disorder—Capecitabine—prostate cancer	2.05e-05	0.000313	CcSEcCtD
Cisplatin—Leukopenia—Docetaxel—prostate cancer	2.05e-05	0.000312	CcSEcCtD
Cisplatin—Anaemia—Capecitabine—prostate cancer	2.05e-05	0.000312	CcSEcCtD
Cisplatin—Immune system disorder—Prednisone—prostate cancer	2.05e-05	0.000312	CcSEcCtD
Cisplatin—Arrhythmia—Prednisone—prostate cancer	2.02e-05	0.000308	CcSEcCtD
Cisplatin—Paraesthesia—Etoposide—prostate cancer	2.02e-05	0.000307	CcSEcCtD
Cisplatin—Pancreatitis—Doxorubicin—prostate cancer	2.01e-05	0.000306	CcSEcCtD
Cisplatin—Dyspnoea—Etoposide—prostate cancer	2e-05	0.000305	CcSEcCtD
Cisplatin—Alopecia—Prednisone—prostate cancer	2e-05	0.000305	CcSEcCtD
Cisplatin—Malaise—Capecitabine—prostate cancer	2e-05	0.000304	CcSEcCtD
Cisplatin—Hypersensitivity—Mitoxantrone—prostate cancer	1.99e-05	0.000303	CcSEcCtD
Cisplatin—Diarrhoea—Estradiol—prostate cancer	1.98e-05	0.000302	CcSEcCtD
Cisplatin—Leukopenia—Capecitabine—prostate cancer	1.98e-05	0.000302	CcSEcCtD
Cisplatin—Convulsion—Docetaxel—prostate cancer	1.98e-05	0.000302	CcSEcCtD
Cisplatin—Malnutrition—Prednisone—prostate cancer	1.97e-05	0.000301	CcSEcCtD
Cisplatin—Erythema—Prednisone—prostate cancer	1.97e-05	0.000301	CcSEcCtD
Cisplatin—Decreased appetite—Etoposide—prostate cancer	1.95e-05	0.000298	CcSEcCtD
Cisplatin—Myalgia—Docetaxel—prostate cancer	1.95e-05	0.000297	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—prostate cancer	1.95e-05	0.000296	CcSEcCtD
Cisplatin—Renal failure—Epirubicin—prostate cancer	1.94e-05	0.000296	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Etoposide—prostate cancer	1.94e-05	0.000295	CcSEcCtD
Cisplatin—Asthenia—Mitoxantrone—prostate cancer	1.94e-05	0.000295	CcSEcCtD
Cisplatin—Neuropathy peripheral—Epirubicin—prostate cancer	1.93e-05	0.000295	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	1.93e-05	0.000295	CcSEcCtD
Cisplatin—Stomatitis—Epirubicin—prostate cancer	1.92e-05	0.000293	CcSEcCtD
Cisplatin—Pain—Etoposide—prostate cancer	1.92e-05	0.000293	CcSEcCtD
Cisplatin—Conjunctivitis—Epirubicin—prostate cancer	1.92e-05	0.000292	CcSEcCtD
Cisplatin—Myalgia—Capecitabine—prostate cancer	1.89e-05	0.000287	CcSEcCtD
Cisplatin—Anxiety—Capecitabine—prostate cancer	1.88e-05	0.000286	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	1.87e-05	0.000285	CcSEcCtD
Cisplatin—Hepatobiliary disease—Epirubicin—prostate cancer	1.87e-05	0.000285	CcSEcCtD
Cisplatin—Oedema—Docetaxel—prostate cancer	1.87e-05	0.000284	CcSEcCtD
Cisplatin—Anaphylactic shock—Docetaxel—prostate cancer	1.87e-05	0.000284	CcSEcCtD
Cisplatin—Discomfort—Capecitabine—prostate cancer	1.86e-05	0.000284	CcSEcCtD
Cisplatin—Vision blurred—Prednisone—prostate cancer	1.86e-05	0.000283	CcSEcCtD
Cisplatin—Infection—Docetaxel—prostate cancer	1.85e-05	0.000283	CcSEcCtD
Cisplatin—Feeling abnormal—Etoposide—prostate cancer	1.85e-05	0.000282	CcSEcCtD
Cisplatin—Diarrhoea—Mitoxantrone—prostate cancer	1.85e-05	0.000282	CcSEcCtD
Cisplatin—Vomiting—Estradiol—prostate cancer	1.84e-05	0.000281	CcSEcCtD
Cisplatin—Nervous system disorder—Docetaxel—prostate cancer	1.83e-05	0.000279	CcSEcCtD
Cisplatin—Ill-defined disorder—Prednisone—prostate cancer	1.83e-05	0.000279	CcSEcCtD
Cisplatin—Thrombocytopenia—Docetaxel—prostate cancer	1.83e-05	0.000279	CcSEcCtD
Cisplatin—Rash—Estradiol—prostate cancer	1.83e-05	0.000278	CcSEcCtD
Cisplatin—Dermatitis—Estradiol—prostate cancer	1.83e-05	0.000278	CcSEcCtD
Cisplatin—Anaemia—Prednisone—prostate cancer	1.82e-05	0.000278	CcSEcCtD
Cisplatin—Tachycardia—Docetaxel—prostate cancer	1.82e-05	0.000278	CcSEcCtD
Cisplatin—Skin disorder—Docetaxel—prostate cancer	1.81e-05	0.000276	CcSEcCtD
Cisplatin—Oedema—Capecitabine—prostate cancer	1.81e-05	0.000275	CcSEcCtD
Cisplatin—Bradycardia—Epirubicin—prostate cancer	1.8e-05	0.000275	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—prostate cancer	1.8e-05	0.000274	CcSEcCtD
Cisplatin—Infection—Capecitabine—prostate cancer	1.8e-05	0.000274	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—prostate cancer	1.79e-05	0.000273	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—prostate cancer	1.78e-05	0.000271	CcSEcCtD
Cisplatin—Anorexia—Docetaxel—prostate cancer	1.78e-05	0.000271	CcSEcCtD
Cisplatin—Malaise—Prednisone—prostate cancer	1.78e-05	0.000271	CcSEcCtD
Cisplatin—Body temperature increased—Etoposide—prostate cancer	1.78e-05	0.000271	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—prostate cancer	1.78e-05	0.000271	CcSEcCtD
Cisplatin—Nervous system disorder—Capecitabine—prostate cancer	1.77e-05	0.00027	CcSEcCtD
Cisplatin—Thrombocytopenia—Capecitabine—prostate cancer	1.77e-05	0.00027	CcSEcCtD
Cisplatin—Tachycardia—Capecitabine—prostate cancer	1.76e-05	0.000269	CcSEcCtD
Cisplatin—Skin disorder—Capecitabine—prostate cancer	1.76e-05	0.000268	CcSEcCtD
Cisplatin—Urinary tract disorder—Epirubicin—prostate cancer	1.75e-05	0.000267	CcSEcCtD
Cisplatin—Hyperhidrosis—Capecitabine—prostate cancer	1.75e-05	0.000266	CcSEcCtD
Cisplatin—Hypotension—Docetaxel—prostate cancer	1.74e-05	0.000266	CcSEcCtD
Cisplatin—Connective tissue disorder—Epirubicin—prostate cancer	1.74e-05	0.000265	CcSEcCtD
Cisplatin—Urethral disorder—Epirubicin—prostate cancer	1.74e-05	0.000265	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—prostate cancer	1.73e-05	0.000263	CcSEcCtD
Cisplatin—Anorexia—Capecitabine—prostate cancer	1.72e-05	0.000263	CcSEcCtD
Cisplatin—Nausea—Estradiol—prostate cancer	1.72e-05	0.000262	CcSEcCtD
Cisplatin—Vomiting—Mitoxantrone—prostate cancer	1.72e-05	0.000262	CcSEcCtD
Cisplatin—Convulsion—Prednisone—prostate cancer	1.71e-05	0.00026	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—prostate cancer	1.71e-05	0.00026	CcSEcCtD
Cisplatin—Rash—Mitoxantrone—prostate cancer	1.7e-05	0.000259	CcSEcCtD
Cisplatin—Dermatitis—Mitoxantrone—prostate cancer	1.7e-05	0.000259	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.7e-05	0.000259	CcSEcCtD
Cisplatin—Hypotension—Capecitabine—prostate cancer	1.69e-05	0.000257	CcSEcCtD
Cisplatin—Myalgia—Prednisone—prostate cancer	1.68e-05	0.000256	CcSEcCtD
Cisplatin—Paraesthesia—Docetaxel—prostate cancer	1.68e-05	0.000255	CcSEcCtD
Cisplatin—Anxiety—Prednisone—prostate cancer	1.67e-05	0.000255	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—prostate cancer	1.67e-05	0.000254	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.67e-05	0.000254	CcSEcCtD
Cisplatin—Dyspnoea—Docetaxel—prostate cancer	1.66e-05	0.000254	CcSEcCtD
Cisplatin—Discomfort—Prednisone—prostate cancer	1.66e-05	0.000253	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—prostate cancer	1.66e-05	0.000252	CcSEcCtD
Cisplatin—Hypersensitivity—Etoposide—prostate cancer	1.65e-05	0.000252	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—prostate cancer	1.65e-05	0.000252	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.65e-05	0.000251	CcSEcCtD
Cisplatin—Flushing—Epirubicin—prostate cancer	1.64e-05	0.000251	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—prostate cancer	1.64e-05	0.000251	CcSEcCtD
Cisplatin—Paraesthesia—Capecitabine—prostate cancer	1.62e-05	0.000247	CcSEcCtD
Cisplatin—Decreased appetite—Docetaxel—prostate cancer	1.62e-05	0.000247	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—prostate cancer	1.62e-05	0.000247	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Docetaxel—prostate cancer	1.61e-05	0.000246	CcSEcCtD
Cisplatin—Asthenia—Etoposide—prostate cancer	1.61e-05	0.000246	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—prostate cancer	1.61e-05	0.000246	CcSEcCtD
Cisplatin—Dyspnoea—Capecitabine—prostate cancer	1.61e-05	0.000246	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisone—prostate cancer	1.61e-05	0.000245	CcSEcCtD
Cisplatin—Oedema—Prednisone—prostate cancer	1.61e-05	0.000245	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—prostate cancer	1.61e-05	0.000245	CcSEcCtD
Cisplatin—Nausea—Mitoxantrone—prostate cancer	1.6e-05	0.000244	CcSEcCtD
Cisplatin—Immune system disorder—Epirubicin—prostate cancer	1.6e-05	0.000244	CcSEcCtD
Cisplatin—Infection—Prednisone—prostate cancer	1.6e-05	0.000244	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—prostate cancer	1.6e-05	0.000243	CcSEcCtD
Cisplatin—Pain—Docetaxel—prostate cancer	1.6e-05	0.000243	CcSEcCtD
Cisplatin—Arrhythmia—Epirubicin—prostate cancer	1.58e-05	0.000241	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—prostate cancer	1.58e-05	0.000241	CcSEcCtD
Cisplatin—Nervous system disorder—Prednisone—prostate cancer	1.58e-05	0.000241	CcSEcCtD
Cisplatin—Tachycardia—Prednisone—prostate cancer	1.57e-05	0.000239	CcSEcCtD
Cisplatin—Decreased appetite—Capecitabine—prostate cancer	1.57e-05	0.000239	CcSEcCtD
Cisplatin—Alopecia—Epirubicin—prostate cancer	1.57e-05	0.000239	CcSEcCtD
Cisplatin—Skin disorder—Prednisone—prostate cancer	1.56e-05	0.000238	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Capecitabine—prostate cancer	1.56e-05	0.000238	CcSEcCtD
Cisplatin—Hyperhidrosis—Prednisone—prostate cancer	1.56e-05	0.000237	CcSEcCtD
Cisplatin—Pain—Capecitabine—prostate cancer	1.55e-05	0.000236	CcSEcCtD
Cisplatin—Malnutrition—Epirubicin—prostate cancer	1.54e-05	0.000235	CcSEcCtD
Cisplatin—Erythema—Epirubicin—prostate cancer	1.54e-05	0.000235	CcSEcCtD
Cisplatin—Feeling abnormal—Docetaxel—prostate cancer	1.54e-05	0.000234	CcSEcCtD
Cisplatin—Diarrhoea—Etoposide—prostate cancer	1.54e-05	0.000234	CcSEcCtD
Cisplatin—Anorexia—Prednisone—prostate cancer	1.53e-05	0.000234	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—prostate cancer	1.53e-05	0.000234	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—prostate cancer	1.53e-05	0.000233	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—prostate cancer	1.52e-05	0.000232	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—prostate cancer	1.52e-05	0.000232	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—prostate cancer	1.52e-05	0.000232	CcSEcCtD
Cisplatin—Feeling abnormal—Capecitabine—prostate cancer	1.49e-05	0.000227	CcSEcCtD
Cisplatin—Muscle spasms—Epirubicin—prostate cancer	1.48e-05	0.000226	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—prostate cancer	1.48e-05	0.000226	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—prostate cancer	1.48e-05	0.000225	CcSEcCtD
Cisplatin—Body temperature increased—Docetaxel—prostate cancer	1.48e-05	0.000225	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Prednisone—prostate cancer	1.47e-05	0.000223	CcSEcCtD
Cisplatin—Arrhythmia—Doxorubicin—prostate cancer	1.46e-05	0.000223	CcSEcCtD
Cisplatin—Vision blurred—Epirubicin—prostate cancer	1.45e-05	0.000222	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—prostate cancer	1.45e-05	0.000221	CcSEcCtD
Cisplatin—Paraesthesia—Prednisone—prostate cancer	1.45e-05	0.00022	CcSEcCtD
Cisplatin—Ill-defined disorder—Epirubicin—prostate cancer	1.43e-05	0.000218	CcSEcCtD
Cisplatin—Body temperature increased—Capecitabine—prostate cancer	1.43e-05	0.000218	CcSEcCtD
Cisplatin—Vomiting—Etoposide—prostate cancer	1.43e-05	0.000218	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—prostate cancer	1.43e-05	0.000218	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—prostate cancer	1.43e-05	0.000218	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—prostate cancer	1.43e-05	0.000217	CcSEcCtD
Cisplatin—Rash—Etoposide—prostate cancer	1.42e-05	0.000216	CcSEcCtD
Cisplatin—Dermatitis—Etoposide—prostate cancer	1.41e-05	0.000216	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—prostate cancer	1.41e-05	0.000214	CcSEcCtD
Cisplatin—Decreased appetite—Prednisone—prostate cancer	1.4e-05	0.000213	CcSEcCtD
Cisplatin—Malaise—Epirubicin—prostate cancer	1.39e-05	0.000212	CcSEcCtD
Cisplatin—Leukopenia—Epirubicin—prostate cancer	1.38e-05	0.00021	CcSEcCtD
Cisplatin—Hypersensitivity—Docetaxel—prostate cancer	1.38e-05	0.00021	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—prostate cancer	1.37e-05	0.000209	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—prostate cancer	1.35e-05	0.000205	CcSEcCtD
Cisplatin—Asthenia—Docetaxel—prostate cancer	1.34e-05	0.000204	CcSEcCtD
Cisplatin—Convulsion—Epirubicin—prostate cancer	1.34e-05	0.000204	CcSEcCtD
Cisplatin—Nausea—Etoposide—prostate cancer	1.33e-05	0.000203	CcSEcCtD
Cisplatin—Hypersensitivity—Capecitabine—prostate cancer	1.33e-05	0.000203	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisone—prostate cancer	1.33e-05	0.000202	CcSEcCtD
Cisplatin—Ill-defined disorder—Doxorubicin—prostate cancer	1.32e-05	0.000202	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—prostate cancer	1.32e-05	0.000201	CcSEcCtD
Cisplatin—Myalgia—Epirubicin—prostate cancer	1.31e-05	0.0002	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—prostate cancer	1.31e-05	0.000199	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.3e-05	0.000199	CcSEcCtD
Cisplatin—Discomfort—Epirubicin—prostate cancer	1.3e-05	0.000198	CcSEcCtD
Cisplatin—Asthenia—Capecitabine—prostate cancer	1.3e-05	0.000198	CcSEcCtD
Cisplatin—Malaise—Doxorubicin—prostate cancer	1.29e-05	0.000196	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—prostate cancer	1.28e-05	0.000195	CcSEcCtD
Cisplatin—Diarrhoea—Docetaxel—prostate cancer	1.28e-05	0.000195	CcSEcCtD
Cisplatin—Body temperature increased—Prednisone—prostate cancer	1.27e-05	0.000194	CcSEcCtD
Cisplatin—Oedema—Epirubicin—prostate cancer	1.26e-05	0.000192	CcSEcCtD
Cisplatin—Anaphylactic shock—Epirubicin—prostate cancer	1.26e-05	0.000192	CcSEcCtD
Cisplatin—Infection—Epirubicin—prostate cancer	1.25e-05	0.000191	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—prostate cancer	1.24e-05	0.000188	CcSEcCtD
Cisplatin—Diarrhoea—Capecitabine—prostate cancer	1.24e-05	0.000188	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—prostate cancer	1.23e-05	0.000188	CcSEcCtD
Cisplatin—Thrombocytopenia—Epirubicin—prostate cancer	1.23e-05	0.000188	CcSEcCtD
Cisplatin—Tachycardia—Epirubicin—prostate cancer	1.23e-05	0.000187	CcSEcCtD
Cisplatin—Skin disorder—Epirubicin—prostate cancer	1.22e-05	0.000186	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—prostate cancer	1.22e-05	0.000185	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—prostate cancer	1.22e-05	0.000185	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—prostate cancer	1.21e-05	0.000185	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.21e-05	0.000184	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—prostate cancer	1.2e-05	0.000183	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—prostate cancer	1.2e-05	0.000183	CcSEcCtD
Cisplatin—Vomiting—Docetaxel—prostate cancer	1.19e-05	0.000181	CcSEcCtD
Cisplatin—Hypersensitivity—Prednisone—prostate cancer	1.19e-05	0.000181	CcSEcCtD
Cisplatin—Rash—Docetaxel—prostate cancer	1.18e-05	0.000179	CcSEcCtD
Cisplatin—Hypotension—Epirubicin—prostate cancer	1.18e-05	0.000179	CcSEcCtD
Cisplatin—Dermatitis—Docetaxel—prostate cancer	1.18e-05	0.000179	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—prostate cancer	1.16e-05	0.000178	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—prostate cancer	1.16e-05	0.000178	CcSEcCtD
Cisplatin—Infection—Doxorubicin—prostate cancer	1.16e-05	0.000176	CcSEcCtD
Cisplatin—Asthenia—Prednisone—prostate cancer	1.15e-05	0.000176	CcSEcCtD
Cisplatin—Vomiting—Capecitabine—prostate cancer	1.15e-05	0.000175	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.15e-05	0.000175	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—prostate cancer	1.14e-05	0.000174	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—prostate cancer	1.14e-05	0.000174	CcSEcCtD
Cisplatin—Rash—Capecitabine—prostate cancer	1.14e-05	0.000174	CcSEcCtD
Cisplatin—Dermatitis—Capecitabine—prostate cancer	1.14e-05	0.000173	CcSEcCtD
Cisplatin—Tachycardia—Doxorubicin—prostate cancer	1.14e-05	0.000173	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—prostate cancer	1.13e-05	0.000172	CcSEcCtD
Cisplatin—Paraesthesia—Epirubicin—prostate cancer	1.13e-05	0.000172	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—prostate cancer	1.13e-05	0.000172	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—prostate cancer	1.12e-05	0.000171	CcSEcCtD
Cisplatin—Anorexia—Doxorubicin—prostate cancer	1.11e-05	0.000169	CcSEcCtD
Cisplatin—Nausea—Docetaxel—prostate cancer	1.11e-05	0.000169	CcSEcCtD
Cisplatin—Diarrhoea—Prednisone—prostate cancer	1.1e-05	0.000168	CcSEcCtD
Cisplatin—Decreased appetite—Epirubicin—prostate cancer	1.09e-05	0.000167	CcSEcCtD
Cisplatin—Hypotension—Doxorubicin—prostate cancer	1.09e-05	0.000166	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Epirubicin—prostate cancer	1.09e-05	0.000166	CcSEcCtD
Cisplatin—Pain—Epirubicin—prostate cancer	1.08e-05	0.000164	CcSEcCtD
Cisplatin—Nausea—Capecitabine—prostate cancer	1.07e-05	0.000164	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.06e-05	0.000162	CcSEcCtD
Cisplatin—Paraesthesia—Doxorubicin—prostate cancer	1.05e-05	0.000159	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—prostate cancer	1.04e-05	0.000158	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—prostate cancer	1.04e-05	0.000158	CcSEcCtD
Cisplatin—Vomiting—Prednisone—prostate cancer	1.02e-05	0.000156	CcSEcCtD
Cisplatin—Rash—Prednisone—prostate cancer	1.01e-05	0.000155	CcSEcCtD
Cisplatin—Dermatitis—Prednisone—prostate cancer	1.01e-05	0.000155	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—prostate cancer	1.01e-05	0.000154	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.01e-05	0.000153	CcSEcCtD
Cisplatin—Pain—Doxorubicin—prostate cancer	9.96e-06	0.000152	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—prostate cancer	9.95e-06	0.000152	CcSEcCtD
Cisplatin—Feeling abnormal—Doxorubicin—prostate cancer	9.6e-06	0.000146	CcSEcCtD
Cisplatin—Nausea—Prednisone—prostate cancer	9.56e-06	0.000146	CcSEcCtD
Cisplatin—Hypersensitivity—Epirubicin—prostate cancer	9.27e-06	0.000141	CcSEcCtD
Cisplatin—Body temperature increased—Doxorubicin—prostate cancer	9.21e-06	0.00014	CcSEcCtD
Cisplatin—Asthenia—Epirubicin—prostate cancer	9.03e-06	0.000138	CcSEcCtD
Cisplatin—Diarrhoea—Epirubicin—prostate cancer	8.61e-06	0.000131	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—prostate cancer	8.58e-06	0.000131	CcSEcCtD
Cisplatin—Asthenia—Doxorubicin—prostate cancer	8.36e-06	0.000127	CcSEcCtD
Cisplatin—Vomiting—Epirubicin—prostate cancer	8e-06	0.000122	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—prostate cancer	7.97e-06	0.000121	CcSEcCtD
Cisplatin—Rash—Epirubicin—prostate cancer	7.94e-06	0.000121	CcSEcCtD
Cisplatin—Dermatitis—Epirubicin—prostate cancer	7.93e-06	0.000121	CcSEcCtD
Cisplatin—Nausea—Epirubicin—prostate cancer	7.48e-06	0.000114	CcSEcCtD
Cisplatin—Vomiting—Doxorubicin—prostate cancer	7.41e-06	0.000113	CcSEcCtD
Cisplatin—Rash—Doxorubicin—prostate cancer	7.34e-06	0.000112	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—prostate cancer	7.34e-06	0.000112	CcSEcCtD
Cisplatin—Nausea—Doxorubicin—prostate cancer	6.92e-06	0.000105	CcSEcCtD
Cisplatin—PTGS2—Metabolism—CYP19A1—prostate cancer	6.65e-07	1.01e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MED12—prostate cancer	6.65e-07	1.01e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NOS3—prostate cancer	6.63e-07	1.01e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—LPL—prostate cancer	6.63e-07	1.01e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GNG5—prostate cancer	6.6e-07	1.01e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GGT1—prostate cancer	6.59e-07	1e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—prostate cancer	6.58e-07	1e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PDGFRB—prostate cancer	6.57e-07	1e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—MTHFR—prostate cancer	6.55e-07	9.99e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HPGDS—prostate cancer	6.49e-07	9.89e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NCOA1—prostate cancer	6.49e-07	9.88e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—MTHFR—prostate cancer	6.49e-07	9.88e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP2C19—prostate cancer	6.45e-07	9.83e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARA—prostate cancer	6.43e-07	9.8e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—RXRA—prostate cancer	6.42e-07	9.78e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.4e-07	9.75e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP19A1—prostate cancer	6.39e-07	9.74e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARA—prostate cancer	6.36e-07	9.7e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOA3—prostate cancer	6.35e-07	9.68e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERCC2—prostate cancer	6.35e-07	9.68e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTT1—prostate cancer	6.29e-07	9.59e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ACHE—prostate cancer	6.29e-07	9.59e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.24e-07	9.52e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.24e-07	9.51e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP2A6—prostate cancer	6.22e-07	9.48e-06	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTEN—prostate cancer	6.22e-07	9.48e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB3—prostate cancer	6.21e-07	9.46e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGFR2—prostate cancer	6.2e-07	9.45e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—COMT—prostate cancer	6.18e-07	9.42e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—RXRA—prostate cancer	6.17e-07	9.4e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTP1—prostate cancer	6.15e-07	9.38e-06	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CB—prostate cancer	6.12e-07	9.32e-06	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	6.11e-07	9.31e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CG—prostate cancer	6.1e-07	9.3e-06	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—prostate cancer	6.06e-07	9.24e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HPGDS—prostate cancer	6.06e-07	9.24e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ITPR1—prostate cancer	6.06e-07	9.23e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKR1C3—prostate cancer	6.05e-07	9.22e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CAV1—prostate cancer	6.04e-07	9.21e-06	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—prostate cancer	6.04e-07	9.21e-06	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—prostate cancer	6.04e-07	9.2e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP2C19—prostate cancer	6.02e-07	9.18e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PRKACB—prostate cancer	6.02e-07	9.17e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CAV1—prostate cancer	5.98e-07	9.12e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTHFR—prostate cancer	5.97e-07	9.09e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP17A1—prostate cancer	5.96e-07	9.08e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.95e-07	9.07e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TERT—prostate cancer	5.95e-07	9.07e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—COMT—prostate cancer	5.94e-07	9.06e-06	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—EP300—prostate cancer	5.93e-07	9.04e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTP1—prostate cancer	5.92e-07	9.01e-06	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.89e-07	8.98e-06	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—prostate cancer	5.88e-07	8.97e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTT1—prostate cancer	5.88e-07	8.96e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ACHE—prostate cancer	5.88e-07	8.96e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ITPR1—prostate cancer	5.82e-07	8.87e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP2A6—prostate cancer	5.81e-07	8.86e-06	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—prostate cancer	5.8e-07	8.84e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.79e-07	8.82e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—INS—prostate cancer	5.78e-07	8.8e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TYMS—prostate cancer	5.72e-07	8.72e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HIF1A—prostate cancer	5.69e-07	8.67e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NCOA2—prostate cancer	5.68e-07	8.65e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CREBBP—prostate cancer	5.66e-07	8.62e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTM1—prostate cancer	5.66e-07	8.62e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKR1C3—prostate cancer	5.65e-07	8.62e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PRKACB—prostate cancer	5.62e-07	8.57e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP17A1—prostate cancer	5.57e-07	8.48e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—LPL—prostate cancer	5.55e-07	8.46e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CG—prostate cancer	5.51e-07	8.39e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CAV1—prostate cancer	5.51e-07	8.39e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TYMS—prostate cancer	5.5e-07	8.38e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.49e-07	8.37e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CG—prostate cancer	5.45e-07	8.3e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTM1—prostate cancer	5.44e-07	8.28e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC5A5—prostate cancer	5.42e-07	8.25e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CD—prostate cancer	5.36e-07	8.17e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP1A1—prostate cancer	5.36e-07	8.17e-06	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—prostate cancer	5.35e-07	8.15e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—LPL—prostate cancer	5.34e-07	8.13e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ERCC2—prostate cancer	5.32e-07	8.1e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOA2—prostate cancer	5.3e-07	8.08e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP2E1—prostate cancer	5.29e-07	8.06e-06	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTEN—prostate cancer	5.29e-07	8.06e-06	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—prostate cancer	5.28e-07	8.04e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NQO1—prostate cancer	5.23e-07	7.97e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—INS—prostate cancer	5.21e-07	7.94e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BAD—prostate cancer	5.18e-07	7.89e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—INS—prostate cancer	5.16e-07	7.86e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TH—prostate cancer	5.16e-07	7.86e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP1A1—prostate cancer	5.15e-07	7.85e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ERCC2—prostate cancer	5.11e-07	7.79e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CREBBP—prostate cancer	5.11e-07	7.78e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP3A4—prostate cancer	5.1e-07	7.77e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NOS3—prostate cancer	5.06e-07	7.72e-06	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—prostate cancer	5.06e-07	7.71e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC5A5—prostate cancer	5.06e-07	7.71e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CREBBP—prostate cancer	5.05e-07	7.7e-06	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—EP300—prostate cancer	5.04e-07	7.68e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1B1—prostate cancer	5.01e-07	7.64e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APC—prostate cancer	5.01e-07	7.64e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MTHFR—prostate cancer	5e-07	7.62e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGF—prostate cancer	4.96e-07	7.55e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IRS1—prostate cancer	4.96e-07	7.55e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP2E1—prostate cancer	4.94e-07	7.53e-06	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—prostate cancer	4.94e-07	7.52e-06	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—prostate cancer	4.93e-07	7.52e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARA—prostate cancer	4.9e-07	7.47e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NQO1—prostate cancer	4.89e-07	7.45e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GGT1—prostate cancer	4.86e-07	7.4e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CD—prostate cancer	4.84e-07	7.38e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TH—prostate cancer	4.82e-07	7.34e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—GSK3B—prostate cancer	4.81e-07	7.33e-06	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—prostate cancer	4.81e-07	7.32e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MTHFR—prostate cancer	4.8e-07	7.32e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CD—prostate cancer	4.79e-07	7.3e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.78e-07	7.29e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NCOA1—prostate cancer	4.78e-07	7.29e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP3A4—prostate cancer	4.77e-07	7.26e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—INS—prostate cancer	4.75e-07	7.23e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.74e-07	7.22e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP19A1—prostate cancer	4.72e-07	7.18e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARA—prostate cancer	4.71e-07	7.18e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1B1—prostate cancer	4.68e-07	7.14e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CB—prostate cancer	4.68e-07	7.12e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CREBBP—prostate cancer	4.65e-07	7.08e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—prostate cancer	4.63e-07	7.06e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CAV1—prostate cancer	4.61e-07	7.03e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NOS3—prostate cancer	4.57e-07	6.96e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—RXRA—prostate cancer	4.55e-07	6.93e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GGT1—prostate cancer	4.54e-07	6.91e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NOS3—prostate cancer	4.52e-07	6.89e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NCOA1—prostate cancer	4.47e-07	6.81e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAP2K1—prostate cancer	4.44e-07	6.76e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CAV1—prostate cancer	4.43e-07	6.75e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CD—prostate cancer	4.41e-07	6.72e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP19A1—prostate cancer	4.4e-07	6.71e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.4e-07	6.71e-06	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—prostate cancer	4.39e-07	6.69e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—COMT—prostate cancer	4.38e-07	6.68e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTP1—prostate cancer	4.36e-07	6.65e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SERPINE1—prostate cancer	4.36e-07	6.64e-06	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—prostate cancer	4.31e-07	6.57e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ITPR1—prostate cancer	4.29e-07	6.54e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—RXRA—prostate cancer	4.25e-07	6.48e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGF2—prostate cancer	4.22e-07	6.43e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CB—prostate cancer	4.22e-07	6.43e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CG—prostate cancer	4.2e-07	6.4e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—prostate cancer	4.18e-07	6.37e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CB—prostate cancer	4.18e-07	6.36e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS3—prostate cancer	4.16e-07	6.34e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—prostate cancer	4.14e-07	6.3e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.13e-07	6.3e-06	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—prostate cancer	4.13e-07	6.3e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—COMT—prostate cancer	4.1e-07	6.24e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTP1—prostate cancer	4.08e-07	6.21e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TYMS—prostate cancer	4.06e-07	6.18e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—JAK2—prostate cancer	4.05e-07	6.16e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTEN—prostate cancer	4.04e-07	6.16e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CG—prostate cancer	4.04e-07	6.15e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ITPR1—prostate cancer	4.01e-07	6.11e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTM1—prostate cancer	4.01e-07	6.11e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—INS—prostate cancer	3.98e-07	6.06e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MDM2—prostate cancer	3.95e-07	6.02e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.94e-07	6.01e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—LPL—prostate cancer	3.94e-07	6e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CREBBP—prostate cancer	3.89e-07	5.93e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—prostate cancer	3.89e-07	5.93e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—EP300—prostate cancer	3.85e-07	5.87e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CB—prostate cancer	3.84e-07	5.86e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—INS—prostate cancer	3.82e-07	5.82e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1A1—prostate cancer	3.8e-07	5.79e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TYMS—prostate cancer	3.79e-07	5.77e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ERCC2—prostate cancer	3.77e-07	5.74e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTM1—prostate cancer	3.75e-07	5.71e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CREBBP—prostate cancer	3.74e-07	5.7e-06	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—prostate cancer	3.73e-07	5.68e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CD—prostate cancer	3.69e-07	5.63e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—LPL—prostate cancer	3.68e-07	5.6e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTEN—prostate cancer	3.65e-07	5.56e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTEN—prostate cancer	3.61e-07	5.5e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1B—prostate cancer	3.61e-07	5.49e-06	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—prostate cancer	3.58e-07	5.46e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.55e-07	5.41e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CD—prostate cancer	3.55e-07	5.41e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTHFR—prostate cancer	3.54e-07	5.4e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ERCC2—prostate cancer	3.52e-07	5.37e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NOS3—prostate cancer	3.49e-07	5.31e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—EP300—prostate cancer	3.48e-07	5.3e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARA—prostate cancer	3.48e-07	5.3e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—EP300—prostate cancer	3.44e-07	5.24e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CTNNB1—prostate cancer	3.41e-07	5.19e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NOS3—prostate cancer	3.35e-07	5.11e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1A—prostate cancer	3.33e-07	5.07e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTEN—prostate cancer	3.32e-07	5.06e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTHFR—prostate cancer	3.31e-07	5.04e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CAV1—prostate cancer	3.27e-07	4.98e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARA—prostate cancer	3.25e-07	4.95e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CB—prostate cancer	3.22e-07	4.9e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EP300—prostate cancer	3.17e-07	4.83e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CB—prostate cancer	3.09e-07	4.71e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SRC—prostate cancer	3.08e-07	4.69e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—prostate cancer	3.06e-07	4.67e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CAV1—prostate cancer	3.05e-07	4.65e-06	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—prostate cancer	3.05e-07	4.64e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CG—prostate cancer	2.98e-07	4.54e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—prostate cancer	2.97e-07	4.52e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.92e-07	4.44e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—prostate cancer	2.85e-07	4.34e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—INS—prostate cancer	2.82e-07	4.29e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.78e-07	4.24e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTEN—prostate cancer	2.78e-07	4.24e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CREBBP—prostate cancer	2.76e-07	4.21e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—prostate cancer	2.76e-07	4.2e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFB1—prostate cancer	2.75e-07	4.19e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—prostate cancer	2.7e-07	4.11e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTEN—prostate cancer	2.67e-07	4.07e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—EP300—prostate cancer	2.65e-07	4.04e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—INS—prostate cancer	2.63e-07	4.01e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CD—prostate cancer	2.62e-07	3.99e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CREBBP—prostate cancer	2.58e-07	3.93e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—prostate cancer	2.57e-07	3.92e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—prostate cancer	2.55e-07	3.88e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—EP300—prostate cancer	2.55e-07	3.88e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—prostate cancer	2.55e-07	3.88e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NOS3—prostate cancer	2.47e-07	3.77e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.44e-07	3.73e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—prostate cancer	2.34e-07	3.57e-06	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—prostate cancer	2.33e-07	3.55e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NOS3—prostate cancer	2.31e-07	3.52e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CB—prostate cancer	2.28e-07	3.48e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—prostate cancer	2.26e-07	3.44e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.13e-07	3.25e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—prostate cancer	2.11e-07	3.22e-06	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—prostate cancer	2.1e-07	3.2e-06	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—prostate cancer	2.08e-07	3.17e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—prostate cancer	2.07e-07	3.16e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTEN—prostate cancer	1.97e-07	3e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—prostate cancer	1.96e-07	2.99e-06	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—prostate cancer	1.91e-07	2.92e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.89e-07	2.87e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—EP300—prostate cancer	1.88e-07	2.86e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTEN—prostate cancer	1.84e-07	2.81e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—EP300—prostate cancer	1.76e-07	2.68e-06	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—prostate cancer	1.6e-07	2.44e-06	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—prostate cancer	1.54e-07	2.35e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—prostate cancer	1.39e-07	2.12e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.3e-07	1.98e-06	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—prostate cancer	1.14e-07	1.73e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—prostate cancer	1.06e-07	1.62e-06	CbGpPWpGaD
